CONNEX-2

Effects of BI 425809 in schizophrenia patients

Purpose of the study

To evaluate efficacy of BI 425809 (a glycine transporter inhibitor) on cognitive functioning in patients with schizophrenia.

Researchers

Sanne Brederoo, Pernell Willemsen, Priscilla Oomen, prof. dr. Iris Sommer

Date

2021-09-01
  - 2023-12-01

Participants

Patients with schizophrenia, aged 18-50 years, with cognitive deficits.